Status:
TERMINATED
Implementation of an Evidence Based Smoking Cessation Strategy (SMOCC) for Patients With COPD in Primary Care
Lead Sponsor:
Radboud University Medical Center
Collaborating Sponsors:
ZonMw: The Netherlands Organisation for Health Research and Development
Conditions:
COPD
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
A controlled study demonstrated that a smoking cessation protocol in routine primary care, specifically targeted at patients with COPD (SMOCC), doubled the quit rates. The protocol was tested under op...
Detailed Description
COPD is an increasing cause of death and morbidity and smoking is its primary cause. Professional smoking cessation treatment is very cost-effective and therefore recommended by national guidelines. A...
Eligibility Criteria
Inclusion
- COPD
- Smoking
- Age 40 years or over
Exclusion
- Under control of lung specialist
- Not Dutch-speaking
- Serious physical of psychiatric comorbidity
- Under 40 years of age
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2008
Estimated Enrollment :
2700 Patients enrolled
Trial Details
Trial ID
NCT00294905
Start Date
March 1 2006
End Date
June 1 2008
Last Update
September 23 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboud University Nijmegen Medical Centre, Centre for Quality of Care Research (WOK)
117 Kwazo, Postbus 9101, 6500 Hb, Netherlands, Nijmegen